1671 related articles for article (PubMed ID: 28413025)
1. Biochemical and Biological Attributes of Matrix Metalloproteinases.
Cui N; Hu M; Khalil RA
Prog Mol Biol Transl Sci; 2017; 147():1-73. PubMed ID: 28413025
[TBL] [Abstract][Full Text] [Related]
2. Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.
Wang X; Khalil RA
Adv Pharmacol; 2018; 81():241-330. PubMed ID: 29310800
[TBL] [Abstract][Full Text] [Related]
3. Matrix Metalloproteinases in Remodeling of Lower Extremity Veins and Chronic Venous Disease.
Chen Y; Peng W; Raffetto JD; Khalil RA
Prog Mol Biol Transl Sci; 2017; 147():267-299. PubMed ID: 28413031
[TBL] [Abstract][Full Text] [Related]
4. Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.
Liu J; Khalil RA
Prog Mol Biol Transl Sci; 2017; 148():355-420. PubMed ID: 28662828
[TBL] [Abstract][Full Text] [Related]
5. Matrix Metalloproteinases as Regulators of Vein Structure and Function: Implications in Chronic Venous Disease.
MacColl E; Khalil RA
J Pharmacol Exp Ther; 2015 Dec; 355(3):410-28. PubMed ID: 26319699
[TBL] [Abstract][Full Text] [Related]
6. [The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis].
Fink K; Boratyński J
Postepy Hig Med Dosw (Online); 2012 Sep; 66():609-28. PubMed ID: 23001203
[TBL] [Abstract][Full Text] [Related]
7. Structural and functional role of invariant water molecules in matrix metalloproteinases: a data-mining approach.
Kumar H; Mandal SK; Gogoi P; Kanaujia SP
J Biomol Struct Dyn; 2022; 40(20):10074-10085. PubMed ID: 34121627
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs.
Jabłońska-Trypuć A; Matejczyk M; Rosochacki S
J Enzyme Inhib Med Chem; 2016; 31(sup1):177-183. PubMed ID: 27028474
[TBL] [Abstract][Full Text] [Related]
9. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation.
Reynolds JJ
Oral Dis; 1996 Mar; 2(1):70-6. PubMed ID: 8957940
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases in wound repair (review).
Ravanti L; Kähäri VM
Int J Mol Med; 2000 Oct; 6(4):391-407. PubMed ID: 10998429
[TBL] [Abstract][Full Text] [Related]
11. Matrix metaloproteinases in vascular pathology.
Simões G; Pereira T; Caseiro A
Microvasc Res; 2022 Sep; 143():104398. PubMed ID: 35671836
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting.
Abdel-Hamid NM; Abass SA
Mol Biol Rep; 2021 Sep; 48(9):6525-6538. PubMed ID: 34379286
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.
Raffetto JD; Khalil RA
Biochem Pharmacol; 2008 Jan; 75(2):346-59. PubMed ID: 17678629
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases (MMPs) in health and disease: an overview.
Malemud CJ
Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
[TBL] [Abstract][Full Text] [Related]
15. Biology of metalloproteinases.
Amălinei C; Căruntu ID; Bălan RA
Rom J Morphol Embryol; 2007; 48(4):323-34. PubMed ID: 18060181
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases.
Siasos G; Tousoulis D; Kioufis S; Oikonomou E; Siasou Z; Limperi M; Papavassiliou AG; Stefanadis C
Curr Top Med Chem; 2012; 12(10):1132-48. PubMed ID: 22519444
[TBL] [Abstract][Full Text] [Related]
17. Regulation and involvement of matrix metalloproteinases in vascular diseases.
Amin M; Pushpakumar S; Muradashvili N; Kundu S; Tyagi SC; Sen U
Front Biosci (Landmark Ed); 2016 Jan; 21(1):89-118. PubMed ID: 26709763
[TBL] [Abstract][Full Text] [Related]
18. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
Levin M; Udi Y; Solomonov I; Sagi I
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.
Kucukguven A; Khalil RA
Curr Drug Targets; 2013 Mar; 14(3):287-324. PubMed ID: 23316963
[TBL] [Abstract][Full Text] [Related]
20. Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases.
Kim IS; Yang WS; Kim CH
Curr Med Chem; 2023; 30(18):2075-2112. PubMed ID: 36017851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
